Extraction of antibiotics identified in the EU Watch List 2020 from hospital wastewater using hydrophobic eutectic solvents and terpenoids
The increasing consumption of pharmaceuticals, along with the ineffectiveness of conventional wastewater treatment, has resulted in an increased presence of these pollutants in both drinking water supplies and aquatic environments. The potential adverse health effects and environmental impact of the...
| Autores: | , , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Fecha de publicación: | 2022 |
| País: | España |
| Institución: | Universidad Complutense de Madrid (UCM) |
| Repositorio: | Docta Complutense |
| Idioma: | inglés |
| OAI Identifier: | oai:docta.ucm.es:20.500.14352/71778 |
| Acceso en línea: | https://hdl.handle.net/20.500.14352/71778 |
| Access Level: | acceso abierto |
| Palabra clave: | Antibiotics Terpenoids Eutectic solvents Liquid-liquid extraction Solvent recovery Agua Ingeniería química 2303.31 Química del Agua 3303 Ingeniería y Tecnología Químicas |
| Sumario: | The increasing consumption of pharmaceuticals, along with the ineffectiveness of conventional wastewater treatment, has resulted in an increased presence of these pollutants in both drinking water supplies and aquatic environments. The potential adverse health effects and environmental impact of these chemicals are drawing the attention of several bodies around the world. For instance, some antibiotics such as ciprofloxacin, trimethoprim, and sulfamethoxazole have been included in the most recent European Surface Water Watch List under the EU Water Framework Directive (Decision 2020/1161). The present work proposes the use of terpenoids and eutectic solvents, as effective and green solvents with low toxicity, for multicomponent liquid-liquid extraction of ciprofloxacin, trimethoprim, and sulfamethoxazole from ultrapure water and hospital wastewater. The COSMO-RS method was used for a predictive initial solvent screening. Thymol, carvacrol, eutectic solvents (thymol + fatty acids), and conventional solvents (methyl isobutyl ketone and ethyl acetate) were selected to be used in the experiments. The influence of the volume S/F ratio, aqueous matrix, and pH was analysed. Conventional solvents show significantly lower overall extraction yields than those observed for eutectic solvents and terpenoids at any pH and matrix. Carvacrol presented the most favourable conditions, reaching overall extraction yields above 98.0% (98.9% for trimethoprim, 99.5% for ciprofloxacin, and 97.0% for sulfamethoxazole) with hospital wastewater at pH 5.0 and S/F ratio of 1.00. Carvacrol showed a feasible operating in a continuous extraction column at room temperature, providing effective reuse and regeneration processes in this study.The increasing consumption of pharmaceuticals, along with the ineffectiveness of conventional wastewater treatment, has resulted in an increased presence of these pollutants in both drinking water supplies and aquatic environments. The potential adverse health effects and environmental impact of these chemicals are drawing the attention of several bodies around the world. For instance, some antibiotics such as ciprofloxacin, trimethoprim, and sulfamethoxazole have been included in the most recent European Surface Water Watch List under the EU Water Framework Directive (Decision 2020/1161). The present work proposes the use of terpenoids and eutectic solvents, as effective and green solvents with low toxicity, for multicomponent liquid-liquid extraction of ciprofloxacin, trimethoprim, and sulfamethoxazole from ultrapure water and hospital wastewater. The COSMO-RS method was used for a predictive initial solvent screening. Thymol, carvacrol, eutectic solvents (thymol + fatty acids), and conventional solvents (methyl isobutyl ketone and ethyl acetate) were selected to be used in the experiments. The influence of the volume S/F ratio, aqueous matrix, and pH was analysed. Conventional solvents show significantly lower overall extraction yields than those observed for eutectic solvents and terpenoids at any pH and matrix. Carvacrol presented the most favourable conditions, reaching overall extraction yields above 98.0% (98.9% for trimethoprim, 99.5% for ciprofloxacin, and 97.0% for sulfamethoxazole) with hospital wastewater at pH 5.0 and S/F ratio of 1.00. Carvacrol showed a feasible operating in a continuous extraction column at room temperature, providing effective reuse and regeneration processes in this study. |
|---|